HealthCap

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2025-10-27

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$157M

across 1 round

LATEST ROUND

Series C · $157M · 2025-10-27

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
Hemab Therapeutics Hemab develops targeted therapies for bleeding disorders, focusing on conditions like Glanzmann Thrombasthenia and Von Willebrand Disease.	Series C Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$157M	2025-10-27	[ PART ]